China’s State-Owned Firm SIIC To Set Up $7.28B Fund For Biomedical Investments

Violet Tang
December 28, 2018 — 09:58 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: biomedical biotech China China Everbright chinese healthcare Hong Kong investment manufacturing medicine pharmaceutical Private Equity real estate Renminbi retail Shanghai Shanghai Industrial Investment Shanghai Pharmaceutical Group technology venture capital

Related News:

China To Expand Investment Scope for Its National Social Security Fund

December 8, 2023 — 00:03

Chinese Charitable Foundations Expand Into Alternative Investments To Enhance Returns

November 30, 2023 — 23:50

Bahrain’s Investcorp Targets RMB2-4 Billion Buyout Fund in China

November 25, 2023 — 00:58

Middle Eastern Sovereign Wealth Funds Deepen Investment in China

November 10, 2023 — 23:35

AI-Driven Pharmaceutical Startups Attract Soaring Investor Interest

November 5, 2023 — 03:24

KKR Leads $180 Million Series F Round In Newly-Minted Asian Unicorn Livspace

February 15, 2022 — 03:32

Yufeng Capital: Expect To Live To 120 Years As China Realizes Digital Healthcare

April 24, 2021 — 04:25

China, With 1.4 Billion People, Faces Looming Demographic Crisis

February 18, 2021 — 04:48

What Are China’s Tech Giants: Alibaba, Tencent, Baidu, JD, Doing In Internet Healthcare?

January 30, 2021 — 05:58